Miriam Ficial

7PUBLICATIONS
54CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 06, 2023
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.

Renee Maria Saliby, Talal El Zarif, Ziad Bakouny

|Jun 25, 2021
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes.

Carla Calagua, Miriam Ficial, Caroline S Jansen

|Feb 06, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.

Ziad Bakouny, David A Braun, Sachet A Shukla

|Nov 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma.

Miriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo

|Sep 03, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.

Nizar M Tannir, Sabina Signoretti, Toni K Choueiri

|May 31, 2020
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.

David A Braun, Yue Hou, Ziad Bakouny

Pageof 2

Frequent Collaborators

4 joint publications

Ziad Bakouny

4 joint publications

Sabina Signoretti

3 joint publications

Abdallah Flaifel

3 joint publications

Toni K Choueiri